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Streptococcus suis (S. suis) caused serious disease symptoms in humans and
pigs. S. suis is able to form thick biofilms and this increases the difficulty of
treatment. After growth with 1/2 minimal inhibitory concentration (MIC) of azithromycin,
1/4 MIC of azithromycin, or 1/8 MIC of azithromycin, biofilm formation of S. suis
dose-dependently decreased in the present study. Furthermore, scanning electron
microscopy analysis revealed the obvious effect of azithromycin against biofilm formation
of S. suis. Especially, at two different conditions (1/2 MIC of azithromycin non-
treated cells and treated cells), we carried out comparative proteomic analyses of
cells by using iTRAQ technology. Finally, the results revealed the existence of 19
proteins of varying amounts. Interestingly, several cell surface proteins (such as
ATP-binding cassette superfamily ATP-binding cassette transporter (G7SD52), CpsR
(K0FG35), Cps1/2H (G8DTL7), CPS16F (E9NQ13), putative uncharacterized protein
(G7SER0), NADP-dependent glyceraldehyde-3-phosphate dehydrogenase (G5L259),
putative uncharacterized protein (G7S2D6), amino acid permease (B0M0G6), and NsuB
(G5L351)) were found to be implicated in biofilm formation. More importantly, we also
found that azithromycin affected expression of the genes cps1/2H, cpsR and cps16F.
Especially, after growth with 1/2 MIC of azithromycin and 1/4 MIC of azithromycin, the
capsular polysaccharide content of S. suis was significantly higher.
Keywords: proteomics, Streptococcus suis, azithromycin, biofilm formation, capsular polysaccharide
INTRODUCTION
Streptococcus suis (S. suis) causes serious disease symptoms. It is one of the most important
pathogens, and it is responsible for pneumonia, arthritis, septicemia, and meningitis in pigs and
humans (Bojarska et al., 2016). So far, some researchers have reported that S. suis is able to
form biofilms (Wang et al., 2015; Bojarska et al., 2016; Espinosa et al., 2016). Biofilm structures
are packaged along with proteins, nucleic acids, extracellular polysaccharides (EPS), and other
materials. Microbial cells within biofilm structures are tolerant to the host immune system, heat
treatment, and antibiotics (Nakamura et al., 2016).
In accordance with the antigenicity of the capsule, the S. suis serotypes are determined. capsular
polysaccharide synthesis (CPS) genes are located at the cps locus. Production of the capsule is
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encoded by CPS genes (Smith et al., 1999). Especially, previous
studies have shown that the S. suis serotype 2 mutant impaired in
capsule expression acquire a biofilm-positive phenotype (Tanabe
et al., 2010). Moreover, a hydrophilic capsule may hinder
hydrophobic structures or components important for biofilm
formation by S. suis (Bonifait et al., 2010).
Azithromycin is an antibiotic useful for the treatment of
bacterial infections. It is common knowledge that azithromycin
is derived from erythromycin, belonging to macrolide. Recently,
some reports have showed that subinhibitory concentrations
of azithromycin decreases biofilm formation (Starner et al.,
2008; Gui et al., 2014). Our laboratory recently reported
that sub-minimal inhibitory concentrations (MICs) of tylosin
and sub-MICs of erythromycin decreased biofilm formation
of S. suis ATCC700794 (Zhao et al., 2015; Wang et al.,
2016). However, the relationship between azithromycin and
biofilm formation by S. suis remains poorly understood.
Therefore, the purpose of this study was to describe the use
of proteomics to better understand the impact of azithromycin
on S. suis biofilms in vitro. We found that azithromycin
affected the CPS enzymes. Several cell surface proteins [such as
ATP-binding cassette (ABC) superfamily ATP-binding cassette
transporter (G7SD52), CpsR (K0FG35), Cps1/2H (G8DTL7),
CPS16F (E9NQ13), putative uncharacterized protein (G7SER0),
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
(G5L259), putative uncharacterized protein (G7S2D6), amino
acid permease (B0M0G6), and NsuB (G5L351)] were found to be
implicated in biofilm formation. Especially, after growth with 1/2
MIC of azithromycin and 1/4 MIC of azithromycin, the capsular
polysaccharide (CP) content of S. suis was significantly higher.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
Streptococcus suis ATCC700794 was used in this study. Bacteria
were grown aerobically at 37◦C in Todd-Hewitt broth (THB;
Summus Ltd, Harbin, Heilongjiang, China) or Todd-Hewitt
broth agar (THA) supplemented with 5% (v/v) fetal bovine serum
(Sijiqing Ltd, Hangzhou, Zhejiang, China). The cultures were
used for the biofilm assays and the MIC assays.
Determination of Growth Inhibition
Activity of Azithromycin
Minimal inhibitory concentration assays of azithromycin were
done three times (refer to Yang et al., 2015), with a few
modifications. Briefly, S. suis ATCC700794 was grown aerobically
at 37◦C in THB (Summus Ltd, Harbin, Heilongjiang, China)
overnight. The overnight cultures were diluted in sterile
physiological saline (corresponding to 1 × 108 colony-forming
units /ml). Then, dilute the cultures of S. suis ATCC700794 1:100
using sterile THB (Summus Ltd, Harbin, Heilongjiang, China).
Finally, samples (100µl) were added to the wells of a 96-well plate
(Corning Costar R©3599, Corning, NY, USA) containing serial
dilutions of azithromycin in culture medium. Control bacteria
were cultivated in the absence of azithromycin. The MIC was
determined as the lowest concentration of azithromycin that
completely inhibited S. suis growth after incubation for 24 h at
37◦C.
The growth rates of S. suis ATCC700794 treated with 1/2
MIC of azithromycin and untreated S. suis ATCC700794 were
analyzed (refer to Yang et al., 2015). Briefly, S. suis ATCC700794
treated without azithromycin and S. suis ATCC700794 treated
with azithromycin (1/2 MIC) were incubated at 37◦C for 12 h.
Then, the samples were taken every hour for measuring OD
600 nm.
Biofilm Assay
Overnight cultures of S. suis were diluted in sterile THB
supplemented with 5% (v/v) fetal bovine serum (corresponding
to 1× 108 colony-forming units/ml). Then, the diluted overnight
cultures (200 µl) was grown (24 h) in a 96-well plate (Corning
Costar R© 3599, Corning, NY, USA) in the presence of 1/2 MIC, 1/4
MIC, 1/8 MIC, or 1/16 MIC of azithromycin. S. suis ATCC700794
treated without azithromycin was served as a control. Biofilms
were treated as described by Yang et al. (2015) with some
modifications. Briefly, the medium, free-floating bacteria, and
loosely bound biofilm were then removed by aspiration, and the
wells were washed three times with sterile physiological saline.
The remaining attached bacteria were fixed with 200 µl of 99%
methanol (Guoyao Ltd, China) per well, and then the wells were
left to dry. The wells were dyed for 30 min with 200 µl of 0.1%
crystal violet (Sularbao Ltd, Beijing, China) per well. The stain
was washed with water. Then, the dye was solubilized with 200µl
of 33% glacial acetic acid per well. Finally, the samples were
measured the absorbance at 570 nm.
Scanning Electron Microscopy
The biofilm structure of S. suis was observed by scanning electron
microscopy (refer to Yang et al., 2015). Briefly, overnight cultures
of S. suis were diluted in sterile THB supplemented with 5% (v/v)
fetal bovine serum (corresponding to 1 × 108 colony-forming
units/ml). Then, the diluted overnight cultures with 1/2 MIC
of azithromycin or without azithromycin were added into wells
of a six-well plate containing rough glass slide or glass slide.
Free-floating bacteria and medium were removed after 24 h in
culture. The biofilms were incubated overnight in fixation buffer,
washed with cacodylate buffer and post-fixed for 90 min at room
temperature in 1% (w/v) osmic acid containing 2 mM potassium
ferrocyanide and 6% (w/v) sucrose in cacodylate buffer. Samples
were dehydrated through a graded series of ethanol (50, 70, 95,
and 100%), critical point dried, gold sputtered and examined
using a scanning electron microscopy.
iTRAQ Analysis
Protein was extracted from S. suis cells at two different conditions
(1/2 MIC of azithromycin-treated cells and non-treated cells).
iTRAQ analysis was implemented at Shanghai Applied Protein
Technology Co. Ltd (APT, Shanghai, China). Three biological
replicates were evaluated to minimize the influence of less reliable
quantitative information. iTRAQ analyses were performed as
described by Zhao et al. (2015). Briefly, protein digestion
was performed according to the FASP procedure and the
resulting peptide mixture was labeled using the 8-plex iTRAQ
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reagent. iTRAQ-labeled peptides were fractionated by strong
cation exchange (SCX) chromatography using the AKTA Purifier
system. LC–MS/MS analysis was performed on a Q Exactive mass
spectrometer that was coupled to Easy nLC (Proxeon Biosystems,
now Thermo Fisher Scientific).
Sequence Database Searching and Data
Analysis
Sequence database searching and data analysis were implemented
at Shanghai Applied Protein Technology Co. Ltd (APT, Shanghai,
China). Briefly, MS/MS spectra were searched using MASCOT
engine embedded into Proteome Discoverer 1.3 against Uniprot
database (133549 sequences, download at March 3, 2013) and
the decoy database. For protein identification, the following
options were used. Peptide mass tolerance = 20 ppm, MS/MS
tolerance = 0.1 Da, enzyme = Trypsin, missed cleavage = 2,
fixed modification: Carbamidomethyl (C), iTRAQ8plex(K),
iTRAQ8plex (N-term), and variable modification:oxidation (M),
FDR ≤ 0.01.
Quantitative RT-PCR Analysis
We investigated the effect of 1/2 MIC of azithromycin on the
gene expression of CPS enzymes (CpsR, Cps1/2H, and CPS16F).
S. suis was grown to mid-log phase and then the culture medium
was supplemented with 1/2 MIC of azithromycin prior to further
incubate at 37◦C for 24 h. Control cells were incubated in the
absence of azithromycin.
Quantitative RT-PCR were implemented as described by Yang
et al. (2015).
Briefly, bacteria were collected by centrifugation (10,000 × g
for 5 min) and treated with an RNASE REMOVER I
(Huayueyang Ltd, Beijing, China). Total RNA was extracted with
a Bacterial RNA isolating kit (Omega, Beijing, China) according
to the manufacturer’s protocol. RNA was reverse transcribed
using Maloney murine leukemia virus reverse transcriptase
and random hexamers in a S1000TM thermal cycler. Reverse
transcription conditions were 90 min at 42◦C and 15 min at 70◦C.
Real-time PCR was used for quantification of cpsR, cps1/2H, and
cps16F mRNA expression. Relative copy numbers and expression
ratios of selected genes were normalized to the expression of 16S
rRNA gene (housekeeping gene). The 16S rRNA gene was used
as an internal control for specific primers. The specific primers
used for the quantitative RT-PCR were purchased from Takara
and are listed in Table 1. Triplicate reactions were prepared
with 25 µl of PCR mixture containing 12.5 µl of IQ SYBR
Green Supermix, 5 µl of cDNA, 1 µl of gene-specific primer,
and 6.5 µl of RNase- and DNase-free water. The samples were
amplified using a Bio-Rad MyCyclerTM thermal cycler (Bio-Rad
Laboratories).The amplification conditions for cpsR, cps1/2H,
cps16F, and16S rRNA were 94◦C for 10 min followed by 40 cycles
at 94◦C for 15 s, 60◦C for 60 s.
Quantitative Determination of CP
Streptococcus suis ATCC700794 was treated with 1/2 MIC, 1/4
MIC or 1/8 MIC of azithromycin. S. suis ATCC700794 treated
without azithromycin was served as a control. Isolation and
TABLE 1 | Primers used for the quantitative RT-PCR analysis.
Genes Primer sequence
cps1/2H Forward: 5′-GCCTCTTATTCAGGTTAT-3′
Reverse: 5′-GTTCTGCTACTGTTTCTC-3′
cps16F Forward: 5′-TGAACATAATGGAGCAAC-3′
Reverse: 5′-AGGACCAATCCGACAAGC-3′
cpsR Forward: 5′-TTCGGTAGTAGAAGGTTCAAGAC-3’
Reverse: 5′-AACACGCAAAGCTAAATAGGTAT-3′
16s rRNA Forward: 5′-GATATATGGAGGAACACCG-3′
Reverse: 5′-GACCCAACACCTAGCACT-3′
purification of the CP from S. suis ATCC700794 were performed
as described by Yufang et al. (refer to Yufang et al., 2006).
Briefly, a 10-ml overnight culture was used to inoculate 1L
of THB containing 5% (v/v) fetal bovine serum for 24 h at
37◦C. The bacterial cells were recovered by centrifugation and
washed twice with PBS. The pellet was suspended in 100 ml
of glycine buffer containing 100 mg lysozyme (Sigma). After
incubation at 37oC for 8 h, the supernatant was recovered
following centrifugation. The supernatant was treated with 20 mg
of DNase (Sigma) and 10 mg of RNase (Sigma) at 37◦C for
1 h. Proteinase K (20 mg) was added for 2 h at 55◦C. The
supernatant was brought to a concentration of 30% (v/v) ethanol
and allowed to stand at 4◦C for 2 h. The precipitate formed
was removed by centrifugation, and the supernatant was brought
to a concentration of 80% ethanol and allowed to stand at 4◦C
overnight. The precipitate was recovered by centrifugation and
dried. Quantitative determination of the CP was performed as
described by Cuesta et al. (2003). Briefly, the phenol solution
(0.3 ml) and the CP solution (0.6 ml) were added to screw cap
tubes, which were capped and vortex-stirred. Then 1.5 ml of
concentrated sulfuric acid was added directly to the tube. The
tubes were then closed, vortex-stirred for 5 s and incubated for
30 min. All samples were read the absorbances at 490 nm using
distilled water as blank in a UV-7504 spectrophotometer (Jingke
Ltd, Shanghai, China). Standard curve of glucose was performed
as above described. The CP content was expressed according to
the formula: CP content (%) = (C × D × F/W) × 100, where C
is sugar concentration in the sample, D is dilution factor in the
sample, F is conversion factor (3.19), and W is CP weight in the
sample.
Statistical Analysis
Assays were done three times and the means ± standard
deviations were computed. Data were analyzed using the Student
t-test.
RESULTS
Minimal inhibitory concentration of azithromycin against S. suis
ATCC700794 was 32 µg/ml in the present study. Furthermore,
after 10 h incubation at 37◦C, untreated S. suis ATCC 700794
and treated (1/2 MIC of azithromycin) S. suis ATCC 700794
reached stationary phase, indicating no effect on growth rate
of S. suis ATCC700794 (Figure 1). After growth without
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azithromycin (control) or with 1/2 MIC of azithromycin, 1/4
MIC of azithromycin, 1/8 MIC of azithromycin, or 1/16 MIC
of azithromycin, biofilm formation of S. suis was investigated
(Figure 2). When the culture medium was supplemented with
1/2 MIC of azithromycin, 1/4 MIC of azithromycin, or 1/8
MIC of azithromycin, the biofilms of S. suis were significantly
lower in comparison with the control (p < 0.05). However, after
growth with 1/16 MIC of azithromycin, the biofilms were not
significantly affected (p > 0.05).
Scanning electron microscopy analysis was performed to
observe the azithromycin sub-MIC-induced biofilm formation by
S. suis. As shown in Figures 3A,C (control), a thick biofilm made
of aggregates and microcolonies almost completely covered the
surface of the glass slide. However, when the culture medium was
supplemented with 1/2 MIC of azithromycin, individual short
chains of S. suis and individual pairs of S. suis attached to the
glass slide or rough glass slide (Figures 3B,D). Scanning electron
microscopy analysis revealed that 1/2 MIC of azithromycin
significantly decreased biofilm formation by S. suis.
iTRAQ technology was used to compare the patterns of
protein expression at two different conditions (1/2 MIC of
azithromycin treated cells and non-treated cells). When a protein
had both a fold-change of more that a ratio >2.0 or <0.5 (p-
value< 0.05), the protein was considered differentially expressed.
On the basis of the two criteria, 19 differentially expressed
proteins were identified, 12 (63.2%) of which displayed increased,
and 7 (36.8%) displayed decreased abundance (Table 2).
According to the molecular function, these proteins were
classified into following categories: nucleotide binding (4, 21.1%),
DNA binding (1, 5.3%), catalytic activity (7, 36.8%), RNA
binding (1, 5.3%), protein binding (1, 5.3%), structural molecule
activity (1, 5.3%), transporter activity (1, 5.3%), motor activity (1,
5.3%), and unknown molecular function (9, 47.4%). According
FIGURE 1 | Growth curve of ATCC700794 in the absence of
azithromycin and in the presence of 1/2 minimal inhibitory
concentration (MIC) of azithromycin. Data are expressed as
means ± standard deviations.
to the cellular component, these proteins were classified into
following categories: membrane (9, 47.4%), cytoplasm (2, 10.5%),
extracellular (1, 5.3%), cytoskeleton(1, 5.3%), and unknown
cellular component (9, 47.4%). According to the biological
process, these proteins were classified into following categories:
metabolic process (5, 26.3%), cell organization and biogenesis (1,
5.3%), regulation of biological process (1, 5.3%), transport (2,
10.5%), cellular homeostasis (1, 5.3%), and unknown biological
process (12, 63.2%). Detailed information can be found in
Supplementary Table S1. The majority of the proteins were
involved in catalytic activity (7, 36.8%) and metabolism (5,
26.3%). These findings suggested that 1/2 MIC of azithromycin-
treated cells and non-treated cells were subjected to different
pharmic selective pressures, which might result in different
proteome patterns.
When the culture medium was supplemented with 1/2
MIC of azithromycin, expression of the genes cps1/2H was
upregulated (p< 0.05; Figure 4). However, as shown in Figure 4,
when the culture medium was supplemented with 1/2 MIC
of azithromycin, expression of the genes cpsR and cps16F
was downregulated (p < 0.05). As shown in Figure 5, the
CP content, in comparison with the control, was significantly
higher (p < 0.05) after growth with 1/2 MIC and 1/4 MIC of
azithromycin. However, the CP content was not significantly
affected following growth in the presence of 1/8 MIC of
azithromycin (p > 0.05).
DISCUSSION
In the present study, the relationship between biofilm formation
of S. suis and azithromycin have been investigated carefully. Some
researchers have reported that subinhibitory concentrations of
antimicrobial agents (such as moxifloxacin and triclosan) can
either decrease (Pompilio et al., 2010) or increase (Bedran
FIGURE 2 | Effect of sub-MICs of azithromycin on biofilm formation by
Streptococcus suis ATCC700794. Data are expressed as
means ± standard deviations. Controls refer to the absence of azithromycin.
Significantly different (∗p < 0.05) compared to untreated control bacteria.
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et al., 2014) biofilm formation of bacterial pathogens. In the
present study, we found that subinhibitory concentrations of
azithromycin significantly decreased biofilm formation of S. suis.
This finding is consistent with the previous publication (Starner
et al., 2008; Gui et al., 2014).
Cell surface proteins and outer membrane proteins play a
crucial role in biofilm formation of bacterial pathogens. Biofilm
formation of bacterial pathogens mainly included three aspects:
(i) bacterial pathogens adhere to surfaces, (ii) aggregation of
micro-colonies of bacterial pathogens, and (iii) further expansion
of the microbial community. Key stage of biofilm formation of
bacterial pathogens is adhesion to surfaces. Cell surface proteins
and outer membrane proteins may mediate cell attachment to
surfaces.
When bacterial cells and a surface are close to each
other, the biophysical interaction between a surface and
bacterial cells plays an important role in adhesion. Therefore,
cell surface proteins and outer membrane proteins play an
important role in biofilm formation of bacterial pathogens.
Membrane proteins such as OmpA mediate cell adhesion in
Acinetobacter baumannii (Dallo et al., 2010). In the present
study, the expression of ABC superfamily ATP binding cassette
transporter (G7SD52), CpsR (K0FG35), Cps1/2H (G8DTL7),
CPS16F (E9NQ13), putative uncharacterized protein (G7SER0),
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
(G5L259), putative uncharacterized protein (G7S2D6), amino
acid permease (B0M0G6), and NsuB (G5L351) changed; these
proteins belong to membrane proteins and cell-surface proteins
and might be involved in some molecular functions including
transporter activity, nucleotide binding, motor activity, protein
binding and catalytic activity (Supplementary Table S1). We
predicted that these membrane proteins might affect the bacterial
cell-cell interaction. Thus, membrane proteins might play a
significant role in biofilm formation.
Interestingly, ABC superfamily ATP-binding cassette
transporter (G7SD52) and NsuB (G5L351) was up-regulated
in sub-MIC of azithromycin (in this study) and erythromycin-
treated S. suis (Zhao et al., 2015). However, molecular function
and biological process of NsuB (G5L351) are currently unknown.
In future, NsuB (G5L351) should be studied. CpsR (K0FG35)
and CPS16F (E9NQ13) was down-regulated in sub-MIC
of azithromycin (in this study) and erythromycin-treated
FIGURE 3 | Scanning electron micrographs of S. suis ATCC700794 biofilm following growth in THB supplemented without azithromycin [(A or C),
control], or with 1/2 MIC of azithromycin (B or D). Controls refer to the absence of azithromycin.
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TABLE 2 | ITRAQ Identification of differentially expressed proteins.
Accession Proteins Fold changea
Up-regulated proteins
G5L351 NsuB 7.12934739263001
G5KZF5 Putative uncharacterized protein 3.01653085375799
G8DTL7 Cps1/2H 2.02407561418484
G7SFA8 Transcriptional regulator, Cro/CI family 2.57596261219689
G7S2D6 Putative uncharacterized protein 3.00076898311981
Q9EZW2 Elongation factor Tu (Fragment) 3.9674279008791
G7S4L6 Putative uncharacterized protein 2.31735729535592
B0M0G6 Amino acid permease (Fragment) 2.16331972961307
A4W361 Uridine kinase 7.48970780907174
R4NZ92 TPR repeat-containing protein 2.70348016201752
G7SD52 ABC superfamily ATP binding cassette transporter, membrane protein 5.6411425449412
G7S7A9 FAD-dependent pyridine nucleotide-disulfide oxidoreductase 2.96465802924635
Down-regulated proteins
G7SER0 Putative uncharacterized protein 0.206326492539119
G7SHZ3 Bacteriophage protein, putative 0.480729105006118
K0FG35 CpsR 0.369579660174813
G5L259 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase, putative 0.374165986672724
G7RZ18 Sortase-like protein 0.368308683014746
E9NQ13 CPS16F 0.24025009068188
G7SPA1 Putative scaffolding protein 0.324624727229277
a1/2 MIC azithromycin treated vs. non-treated cells.
FIGURE 4 | Relative abundances of cps1/2H, cps16F and cpsR in 1/2
MIC azithromycin-treated and -untreated cell revealed by quantitative
RT-PCR. Data are expressed as means ± standard deviations. The
expression was normalized to 16S rRNA. Controls refer to the absence of
azithromycin. Significantly different (∗p < 0.05) compared to untreated control
bacteria.
S. suis (Zhao et al., 2015). Especially, in the present study,
azithromycin also affected the expression of the other proteins,
for example, Putative uncharacterized protein (G7SER0),
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
(G5L259), putative uncharacterized protein (G7S2D6), and
amino acid permease (B0M0G6). This finding is not consistent
with the previous results of our laboratory showing that
subinhibitory concentrations of erythromycin inhibit biofilm
FIGURE 5 | Determination of capsular polysaccharide content of
S. suis ATCC700794 using a phenol–sulfuric acid method. Data are
expressed as means ± standard deviations. Controls refer to the absence of
azithromycin. Significantly different (∗p < 0.05) compared to untreated control
bacteria.
formation of S. suis (Zhao et al., 2015). It is generally known
that azithromycin is the same class antibiotics as erythromycin,
belonging to macrolide. However, erythromycin did not affect
the expression of the four proteins (Zhao et al., 2015). In future,
this finding should be studied carefully.
ABC transporters are common proteins in bacteria. They
often transport a variety of substrates (for example polypeptides,
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ions and nutrients) (Lin et al., 2014). ABC transporters are also
presumably involved in the export of the competence-stimulating
peptide (autoinducers), which in turn regulate expression of
specific target genes (Li et al., 2002). Moreover, previous studies
have also demonstrated that ABC transporters are important as
they regulate biofilm formation (Selvaraj et al., 2014). Shannon
et al. have reported that ABC transporters are required for biofilm
formation by Pseudomonas fluorescens WCS365 (Hinsa et al.,
2003). Our laboratory recently reported that ABC superfamily
ATP-binding cassette transporter (G7SD52) was up-regulated in
sub-MIC of erythromycin or sub-MIC of tylosin-treated S. suis
(Zhao et al., 2015; Wang et al., 2016). In the present study, ABC
superfamily ATP-binding cassette transporter (G7SD52) was
upregulated in sub-MIC of azithromycin-treated cell (treated vs.
untreated). However, azithromycin did not affect the expression
of histidine kinase of the competence regulon (comD; G5L3D2)
and response regulator (comE; G7S4A2) in the present study.
Interestingly, erythromycin affects the expression of the two
proteins (Zhao et al., 2015). Li et al. (2002) have also found
that comD and comE are implicated in biofilm formation of
S. mutans. So far, the detailed molecular mechanism was still
unknown.
Some researchers have reported that the S. suis mutant
impaired in capsule expression acquire a biofilm-positive
phenotype in the previous publication (Tanabe et al., 2010).
Bonifait et al. have reported that a hydrophilic capsule hinder
hydrophobic components or structures. Moreover, Bonifait et al.
(2010) have also found that the hydrophobic components or
structures play an important role in biofilm formation of S. suis.
Non-encapsulated S. suis strains may form thick biofilms (Benga
et al., 2004). Specifically, in other species, Qin et al. (2013)
have reported that reduced S. pneumoniae CP may increase
biofilm development. Joseph et al. reported that Vibrio vulnificus
CP expression actually inhibited biofilm formation (Joseph and
Wright, 2004). Lakkitjaroen et al. (2014) have reported that
the inactivation of Cps2F (glycosyltransferases) often caused
capsule loss in S. suis. Cps2F and Cps2H may be involved in
the biosynthesis of serotype 2 CP. In this study, azithromycin
affected the biosynthesis of the CPS enzymes, for example,
CpsR (K0FG35), Cps1/2H (G8DTL7), and CPS16F (E9NQ13).
This finding is consistent with the previous results of our
laboratory showing that sub-MIC erythromycin inhibits biofilm
formation of S. suis (Zhao et al., 2015). However, Cps1/2H
(G8DTL7) was downregulated (fold change: 0.30) in sub-MIC
of erythromycin-treated S. suis (Zhao et al., 2015). Interestingly,
Cps1/2H (G8DTL7) was up-regulated (fold change: 2.024) in sub-
MIC of azithromycin-treated S. suis (in this study). It is common
knowledge that azithromycin is derived from erythromycin,
belonging to macrolide. We speculated that azithromycin had
different molecule structure in comparison with erythromycin,
which in turn might generate the different proteome patterns.
However, the detailed molecular mechanism was still unknown.
In future, this finding should be studied carefully. In brief, we
speculated that azithromycin might affect the biosynthesis of
the CP.
Recently, Lee et al. have investigated the role of CP in biofilm
formation in V. vulnificus. V. vulnificus mutant impaired in
CP expression increases cell aggregation, adherence to abiotic
surfaces, and hydrophobicity of the cell surface. In comparison
with wild type, V. vulnificus mutant forms significantly more
biofilm. Furthermore, addition of CP decrease biofilms formation
of a CP-deficient mutant. After the CP-producing wild type is
degraded endogenous CP with an enzyme, the CP-producing
wild type increases biofilm formation (Lee et al., 2013). In
the present study, the CP content, in comparison with the
control, was significantly higher after growth with 1/2 MIC of
azithromycin and 1/4 MIC of azithromycin. Houde et al. have
reported that S. suis mutants impaired in capsule expression
are easily killed by immune cells. Therefore, CP of S. suis is a
significant virulence factor of the bacteria. Furthermore, CP is
also involved in adhesion of the bacteria (Houde et al., 2012). Key
stage of biofilm formation of bacterial pathogens is adhesion to
surfaces. We speculated that azithromycin might affect adhesion
of S. suis by increasing capsular polysaccharide content. In brief,
further examination of the relationship of capsule structure to
biofilms should be studied.
In short, subinhibitory concentrations of azithromycin might
decrease biofilm formation of S. suis in the present study.
At two different conditions (1/2 MIC of azithromycin non-
treated cells and treated cells), we carried out comparative
proteomic analyses of cells by using iTRAQ technology. In
the present study, 19 differentially expressed proteins were
identified, 12 (63.2%) of which displayed increased and 7
(36.8%) displayed decreased abundance. Several cell surface
proteins [such as ABC superfamily ATP-binding cassette
transporter (G7SD52), CpsR (K0FG35), Cps1/2H (G8DTL7),
CPS16F (E9NQ13), putative uncharacterized protein (G7SER0),
NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
(G5L259), putative uncharacterized protein (G7S2D6), Amino
acid permease (B0M0G6), and NsuB (G5L351)] were found to
be implicated in biofilm formation. It is common knowledge
that azithromycin is derived from erythromycin, belonging
to macrolide. We speculated that azithromycin had different
molecule structure in comparison with erythromycin, which in
turn might generate the different proteome patterns. We also
discovered that azithromycin might affect the biosynthesis of the
CP. These data showed a useful starting point for more focused
studies to understand what exactly was going on. However, the
detailed mechanism was still unknown. In future, the relationship
between capsule structure and biofilms of S. suis should be
studied to delineate the complex mechanism.
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